◀ Back to RNF19A
PRKAG1 — RNF19A
Text-mined interactions from Literome
Li et al., Circ Res 2005
(Myocardial Ischemia) :
In isolated heart muscles, the
AMPK activator 5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside ( AICAR )
increased p38 MAPK activation ...
p38 MAPK recruitment to TAB1/AMPK complexes
required AMPK activation and was reduced in ischemic AMPK-deficient transgenic mouse hearts
Ho et al., Biochem Biophys Res Commun 2007
:
In conclusion, increasing
AMPK activity by AICAR and AMPKgamma1 mutation does not
increase p38 MAPK phosphorylation in skeletal muscle
Jo et al., Nat Prod Res 2012
:
Inhibition of
AMPK activity
reduced p38 MAPK phosphorylation, whereas the inhibition of p38 MAPK activity did not affect AMPK phosphorylation